Emergent BioSolutions secured seven biodefense contract modifications from the U.S. Government.
3 reports, 2 independent
Updated Jun 29
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Emergent BioSolutions secured seven biodefense contract modifications from the U.S. Government.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Emergent BioSolutions supports the U.S. smallpox preparedness strategy.Sub-event
- SIGA Technologies received U.S. Government funding under the BARDA 19C Contract for deliveries to the Strategic National Stockpile.Sub-event
Emergent BioSolutions secured seven biodefense contract modifications.1 source
Keep exploring
The entities involved
-
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireEmergent BioSolutions Reports Second Quarter 2025 Financial Results Second Quarter 2025 Total Revenues of $140.9 million, above Q2 guidance by $21 million Second Quarter 2025 Net Loss of $12.0 millio
- Unknown outlet